10X GENOMICS INC

NASDAQ: TXG (10x Genomics, Inc.)

Last update: 18 Mar, 6:26PM

10.51

-0.25 (-2.32%)

  • 1D -2.32%
  • 5D 27.01%
  • 1M 14.74%
  • 6M -33.73%
  • YTD -25.93%
  • 1Y -62.99%
  • 5Y -86.22%
Previous Close 10.76
Open 10.57
Volume 2,591,818
Avg. Volume (3M) 2,601,551
Market Cap 1,285,394,048
Price / Sales 2.04
Price / Book 1.78
52 Weeks Range
9.27 (-11%) — 39.30 (273%)
Earnings Date 28 Apr 2025 - 2 May 2025
Profit Margin -29.90%
Operating Margin (TTM) -30.20%
Diluted EPS (TTM) -1.52
Quarterly Revenue Growth (YOY) -10.30%
Total Debt/Equity (MRQ) 11.63%
Current Ratio (MRQ) 4.97
Operating Cash Flow (TTM) 6.66 M
Levered Free Cash Flow (TTM) 59.82 M
Return on Assets (TTM) -12.77%
Return on Equity (TTM) -25.17%

Market Trend

Short Term Medium Term
Industry Health Information Services (US) Bearish Bearish
Health Information Services (Global) Bearish Bearish
Stock 10x Genomics, Inc. Bearish Bearish

AIStockmoo Score

0.3
Analyst Consensus 1.0
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 0.0
Technical Oscillators -0.5
Average 0.25

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
TXG 1 B - - 1.78
CERT 2 B - - 2.16
SDGR 2 B - - 4.60
PGNY 2 B - 37.54 4.68
GDRX 2 B - 111.25 2.37
OMCL 1 B - 112.15 1.14

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Sector Healthcare
Industry Health Information Services
Investment Style Small Core
% Held by Insiders 2.14%
% Held by Institutions 96.91%

Ownership

Name Date Shares Held
Venrock Management Vi, Llc 30 Sep 2024 2,106,757
52 Weeks Range
9.27 (-11%) — 39.30 (273%)
Price Target Range
12.00 (14%) — 26.00 (147%)
High 26.00 (Morgan Stanley, 147.38%) Buy
Median 14.50 (37.96%)
Low 12.00 (Barclays, 14.18%) Buy
12.00 (JP Morgan, 14.18%) Hold
12.00 (Leerink Partners, 14.18%) Hold
Average 15.88 (51.09%)
Total 5 Buy, 3 Hold
Avg. Price @ Call 11.28
Firm Date Target Price Call Price @ Call
Barclays 10 Apr 2025 12.00 (14.18%) Buy 7.70
14 Feb 2025 15.00 (42.72%) Buy 12.32
Citigroup 04 Mar 2025 15.00 (42.72%) Buy 10.52
13 Feb 2025 20.00 (90.29%) Buy 11.94
Morgan Stanley 14 Feb 2025 26.00 (147.38%) Buy 12.32
Canaccord Genuity 13 Feb 2025 18.00 (71.27%) Buy 11.94
JP Morgan 13 Feb 2025 12.00 (14.18%) Hold 11.94
Leerink Partners 13 Feb 2025 12.00 (14.18%) Hold 11.94
Stifel 13 Feb 2025 18.00 (71.27%) Buy 11.94
UBS 13 Feb 2025 14.00 (33.21%) Hold 11.94

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria